AI Summary
We reviewed 4 live results for abrilada and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biosimilars and Biologic Immunomodulator.
Comparison Table
Recommended
Abrilada
Source: Pfizer Malaysia
Description
Abrilada is a biologic immunomodulator and TNF-alpha inhibitor available as a 40 mg/0.8 mL solution for injection in a pre-filled pen. It is a biosimilar indicated for various autoimmune conditions.
Best for
autoimmune conditions, biologic therapy and TNF-alpha inhibition
View Details
Rating
Abrilada
Source: Pfizer Private Limited
Description
Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases.
Best for
biologic therapy, chronic inflammation management and subcutaneous injection
View Details
Rating
Abrilada (adalimumab-afzb)
Source: Pfizer (Malaysia) Sdn. Bhd.
Description
Abrilada is a prescription biopharmaceutical and a biosimilar to Humira (adalimumab). It functions as a TNF blocker used to treat chronic inflammatory conditions including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa. It is typically available as a 40 mg/0.8 mL solution for injection in a single-dose pre-filled pen, featuring a citrate-free formulation for subcutaneous administration.
Best for
rheumatoid arthritis management, chronic inflammatory conditions, patients seeking biosimilar alternatives, subcutaneous injection therapy and ankylosing spondylitis treatment
View Details
Rating
| Compare | Abrilada | Abrilada | Abrilada (adalimumab-afzb) |
|---|---|---|---|
| Source | Pfizer Malaysia | Pfizer Private Limited | Pfizer (Malaysia) Sdn. Bhd. |
| Description | Abrilada is a biologic immunomodulator and TNF-alpha inhibitor available as a 40 mg/0.8 mL solution for injection in a pre-filled pen. It is a biosimilar indicated for various autoimmune conditions. | Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases. | Abrilada is a prescription biopharmaceutical and a biosimilar to Humira (adalimumab). It functions as a TNF blocker used to treat chronic inflammatory conditions including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa. It is typically available as a 40 mg/0.8 mL solution for injection in a single-dose pre-filled pen, featuring a citrate-free formulation for subcutaneous administration. |
| Best for | autoimmune conditions, biologic therapy and TNF-alpha inhibition | biologic therapy, chronic inflammation management and subcutaneous injection | rheumatoid arthritis management, chronic inflammatory conditions, patients seeking biosimilar alternatives, subcutaneous injection therapy and ankylosing spondylitis treatment |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Abrilada from Pfizer Malaysia."
I picked this because A recognized biosimilar option for patients requiring TNF-alpha inhibitor therapy for autoimmune management in Malaysia.
Share this search
Related Finds